News
Chime Financial (CHYM) stock rose 2.3% in Monday morning trading after Wall Street analysts assigned a mix of Hold and Buy ...
Timothy E. Chiodo of UBS agreed that Chime will continue to gain share in consumer banking, forecasting annual growth of 15% ...
UK government bonds endured a volatile week as initial doubts over the Chancellor's future and concerns about the country's ...
Oil on Monday shrugged off the impact of OPEC+ hiking output more than expected for August as well as concern about the ...
MercadoLibre, Inc. (NASDAQ:MELI) is one of the 11 Best Fintech Stocks to Buy Right Now. On June 2, UBS analysts increased the ...
A potential breakthrough in securing a test slot at Nvidia (NASDAQ:NVDA) could become a major catalyst for Teradyne (NASDAQ:TER) shares, UBS analysts said, estimating that even a modest win may drive ...
Deutsche Bank is reorganizing its wealth management operations in Germany. With new hires from competitors – including UBS – ...
A survey of central bank reserve managers commissioned by UBS finds that nearly half thinks the unthinkable — that the U.S.
Expensify has made pricing and marketing adjustments to attract more new users. Read why my Buy rating for EXFY stock is left ...
ECB Forum in Sintra, global central bankers tackled how monetary policy must adapt to rising geopolitical tensions and ...
Carmakers may begin reducing production volumes now in order not to be stuck with excess inventory after September, so buyers only have weeks left to purchase their favorite model on the cheap.
UBS recently adjusted its price target for UnitedHealth Group from $400 to $385, citing a conservative 2025 earnings outlook ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results